Announcing Our Renewed Partnership with CSL Behring

We are thrilled to announce CSL Behring as a Champion level Impact Sponsor of the Foundation for Peripheral Neuropathy (FPN). Their generous support and commitment to our cause are crucial in advancing our mission.

CSL Behring is a global leader in biotherapeutics, dedicated to improving the quality of life for patients with rare and serious diseases. By partnering with FPN, CSL Behring is helping us elevate our marketing and awareness efforts, ensuring that more people understand and recognize the challenges faced by individuals living with this condition.

Peripheral neuropathy, a condition that affects millions worldwide, often causes debilitating pain and a significant decrease in quality of life. The impact of this condition cannot be overstated. Increased awareness is not just important, it’s essential for early diagnosis, effective treatment, and improved patient outcomes. With CSL Behring’s support, we can amplify our outreach, provide valuable resources, and foster a greater understanding of this condition within the community and beyond.

Thank you, CSL Behring, for your unwavering support. Your commitment to our mission to enhance lives and create a brighter future for all those impacted by peripheral neuropathy is deeply appreciated and truly invaluable.

For more information about CSL Behring and its commitment to improving patient lives, visit its website.

For more information about corporate partnerships like these, please contact Lindsay Colbert at [email protected].

Leave a Comment